WebMiguel de los Rios is an entrepreneur focused on developing novel therapeutics to satisfy unmet needs in human medicine. Prior to Endeavor, he was Founder and CEO at Rift … WebJan 7, 2024 · A new startup has officially emerged from stealth with the raise of its $62 million Series A funding round. Endeavor BioMedicines is led by co-founder and CEO John Hood, who previously led Impact ...
Tristan Harris - Senior Research A.. - Biotheranostics ZoomInfo
WebMar 31, 2024 · (“Saugatuck”) and Rift Biotherapeutics Inc (“Rift”). In connection with the SalvaRx Acquisition, the Company also acquired an option in Nekonal SARL, a Luxembourg- based company holding intellectual property rights for therapeutics and diagnostics in the field of autoimmune disorders and oncology, to participate in the funding of WebAug 14, 2024 · SalvaRx owns 34.99% of Rift Biotherapeutics Inc. ("Rift"), an early stage research and development Delaware company founded to discover and develop first-in-class antibodies implicated in the inflammatory tumour and tumour infiltrating immune cells microenvironment. Rift recently won the Boehringer Ingelheim Innovation prize, entitling it … gut motility clinic calgary
Team - Novoron Bioscience
WebJan 7, 2024 · SAN DIEGO-- ( BUSINESS WIRE )--Endeavor BioMedicines, a biotechnology company developing new treatments targeting the underlying causes of pulmonary … WebRift Biotherapeutics VentureRadar profile. Find out more about Rift Biotherapeutics, Antibodies and Biologics. WebFeb 22, 2024 · Rift Biotherapeutics 2014-2024 Director of Discovery 2008-2014 Education BA Occidental College M. B. A. UCSD's Rady School of Management MBA Rady School of Management at UC San Diego PhD - Biomedical Sciences University of California , San Diego Board Memberships & Affiliations Volunteer Science Writer, Advocate The Clearity … gut motility meaning